Mehta Anurag, Goswami Malini, Sinha Rupal, Dogra Atika
Department of Laboratory Services, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.
Department of Research, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India. Email:
Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2447-2453. doi: 10.22034/APJCP.2018.19.9.2447.
Background: Colorectal cancer (CRC) is a heterogeneous disease with a complex etiology. New prognostic factors need to be investigated. Our present focus is on histopathological significance and prognostic impact of tumor budding in CRC. Material and Methods: A total of 60 treatment-naive consecutive patients undergoing surgical resection of CRCs during the period of January 2011 to December 2013 were included in the study. Details of each related to their demographic and tumor profile were recorded. Hematoxylin and Eosin (H and E) and pan-cytokeratin details of each “case” immunohistochemically stained sections were examined for tumor budding assessment along with clinical features. Results: The most frequent site of involvement was the rectosigmoid and sigmoid colon (31.6%). The majority of the cases were moderately differentiated (75%), showed tumor invasion into the pericolic/subserosal fat (66.6%) and stage III (38.3%). Nodal involvement was present in 47%. Correlations between tumor budding and nodal involvement (p-value 0.039) and AJCC stage (p-value 0.021) were found to be statistically significant. Conclusion: Tumor budding is a promising and powerful predictor of lymph nodal metastasis and a higher stage of tumor and can be used as a marker for high-risk CRC. Routine H and E staining aided by cytokeratin immunostaining allows reproducible grading of tumor budding in CRC cases.
结直肠癌(CRC)是一种病因复杂的异质性疾病。需要研究新的预后因素。我们目前的重点是CRC中肿瘤芽生的组织病理学意义和预后影响。
本研究纳入了2011年1月至2013年12月期间60例未经治疗且连续接受CRC手术切除的患者。记录了每位患者的人口统计学和肿瘤特征的详细信息。对苏木精和伊红(H&E)染色以及每个“病例”免疫组化染色切片的全细胞角蛋白细节进行检查,以评估肿瘤芽生情况,并结合临床特征进行分析。
最常受累的部位是直肠乙状结肠和乙状结肠(31.6%)。大多数病例为中度分化(75%),显示肿瘤侵犯至结肠周围/浆膜下脂肪(66.6%),且处于III期(38.3%)。47%的病例存在淋巴结受累。发现肿瘤芽生与淋巴结受累(p值0.039)和美国癌症联合委员会(AJCC)分期(p值0.021)之间的相关性具有统计学意义。
肿瘤芽生是淋巴结转移和肿瘤更高分期的一个有前景且有力的预测指标,可作为高危CRC的标志物。常规H&E染色辅以细胞角蛋白免疫染色可对CRC病例中的肿瘤芽生进行可重复的分级。